G 
128.08
+5.47%
Close of 9 Nov 2026, in USD
Search any instrument
Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.
At a glance
Figures in USD, from our data supplier.
Revenue
$147.2m
FY2018FY2025
Net income
−$408.4m
FY2018FY2025
Free cash flow
−$299.9m
FY2018FY2025
Shareholders' equity
$2.58bn
FY2018FY2025
Income statement
Fiscal years
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $147.2m | $125.6m | $93.1m | $55.5m | $14.6m | — | — | — |
| Research and development | $195.8m | $322.4m | $338.7m | $329.6m | $460.2m | $192.9m | $167.1m | $223.2m |
| Operating income | −$534.2m | −$2.19bn | −$1.52bn | −$5.44bn | −$1.27bn | −$316.4m | −$255.7m | −$287.5m |
| Net income | −$408.4m | −$2.03bn | −$1.47bn | −$5.40bn | −$1.25bn | −$312.2m | −$244.9m | −$275.7m |
| Diluted earnings per share | -10.03 | -63.54 | -47.20 | -174.16 | -40.18 | -2.26 | -1.96 | -2.42 |
Balance sheet
At each fiscal year end
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | |
|---|---|---|---|---|---|---|---|---|
| Total assets | $2.92bn | $2.98bn | $4.56bn | $5.60bn | $9.74bn | $706.3m | $635.5m | $686.8m |
| Cash and short-term investments | $904.4m | $763.5m | $97.3m | $241.6m | $221.2m | $583.5m | $544.3m | $641.4m |
| Total liabilities | $344.2m | $479.9m | $910.7m | $955.9m | $307.4m | $144.5m | $85.0m | $86.5m |
| Debt | $11.7m | — | — | $13.3m | $13.8m | $5.4m | — | $1.7m |
| Shareholders' equity | $2.58bn | $2.50bn | $3.65bn | $4.65bn | $9.43bn | $561.8m | $550.5m | $600.4m |
| Shares outstanding | 41m | 32m | 31m | 31m | 31m | 138m | 125m | 114m |
Cash flow
Fiscal years
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | |
|---|---|---|---|---|---|---|---|---|
| Cash from operations | −$299.0m | −$577.2m | −$595.8m | −$561.3m | −$688.1m | −$232.0m | −$245.8m | −$209.3m |
| Capital spending | −$909,000 | −$5.2m | −$12.9m | −$22.9m | −$69.9m | −$11.9m | −$3.3m | −$16.0m |
| Free cash flow | −$299.9m | −$582.4m | −$608.7m | −$584.2m | −$758.1m | −$243.9m | −$249.1m | −$225.2m |
Latest quarters
By quarter end
| Jun 2026 | Mar 2026 | Dec 2025 | Sept 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sept 2024 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $44.7m | $40.8m | $43.6m | $36.2m | $35.5m | $31.8m | $38.3m | $28.7m |
| Operating income | −$173.8m | −$135.8m | −$124.4m | −$125.3m | −$158.9m | −$153.6m | −$136.9m | −$183.5m |
| Net income | −$110.2m | −$93.2m | −$99.2m | −$89.0m | −$114.0m | −$106.2m | −$97.1m | −$125.7m |
| Diluted earnings per share | -2.56 | -2.16 | -2.44 | -2.18 | -2.80 | -2.61 | -3.04 | -3.94 |
| Cash from operations | −$80.0m | −$86.0m | −$63.0m | −$63.0m | −$76.0m | −$95.0m | −$93.0m | −$104.0m |
| Total assets | $2.84bn | $2.80bn | $2.92bn | $2.60bn | $2.70bn | $2.85bn | $2.98bn | $3.12bn |
| Cash and short-term investments | $861.6m | $823.1m | $904.4m | $540.1m | $602.8m | $674.6m | $763.5m | $853.6m |
| Debt | $10.7m | $9.9m | $11.7m | $14.0m | $13.7m | $13.0m | $13.3m | $13.5m |
| Shareholders' equity | $2.54bn | $2.50bn | $2.58bn | $2.24bn | $2.31bn | $2.41bn | $2.50bn | $2.59bn |
Financial ratios
Data as of 20 Oct 2026
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | |
|---|---|---|---|---|---|---|---|
| Operating margin | -363.2% | -611.7% | -855.9% | -1336.6% | -8659.0% | — | — |
| Net margin | -277.5% | -1613.9% | -1574.2% | -9719.3% | -8539.4% | — | — |
| Return on equity | -15.8% | -81.0% | -40.2% | -116.2% | -13.2% | -55.6% | — |
| Return on assets | -14.0% | -67.9% | -32.2% | -96.4% | -12.8% | -44.2% | — |
| Free cash flow yield | -6.0% | -14.6% | -15.3% | -14.2% | — | -1.3% | -1.6% |
| Revenue growth | 17.2% | 34.9% | 67.6% | 280.2% | — | — | — |
| Earnings growth | -79.9% | 38.3% | -72.9% | 332.7% | 299.7% | 27.5% | — |
| Current ratio | 11.97x | 10.66x | 0.95x | 2.19x | 2.48x | 7.10x | — |
| Debt to equity | 0.00x | 0.01x | 0.00x | 0.00x | 0.00x | 0.01x | — |
| Equity ratio | 88.2% | 83.9% | 80.0% | 82.9% | 96.8% | 79.5% | — |
| R&D as a share of sales | 133.0% | 256.7% | 363.8% | 593.3% | 3149.5% | — | — |
| Buybacks as a share of market value | -27.7% | -2.7% | -0.2% | 77.5% | — | -10.5% | — |
Growth per year
Compound annual rate
| 3 years | 5 years | 10 years | |
|---|---|---|---|
| Revenue | 38.4% | — | — |
| Operating income | -53.9% | 11.0% | — |
| Net income | -57.7% | 5.5% | — |
Average margins
Over each period
| 1 year | 3 years | 5 years | 10 years | |
|---|---|---|---|---|
| Operating margin | -998.4% | -2297.4% | — | — |
| Net margin | -892.8% | -2206.8% | — | — |
Valuation history
At each fiscal year end
| FY2025 | FY2024 | |
|---|---|---|
| Price to earnings | -4.2 | -0.1 |
| Price to sales | 11.7 | 2.2 |
Market value over time
28 Jun 2024 to 19 Oct 2026, in USD
$478.0m$5.28bn
Share price return
Finished calendar years
| 2025 | 2024 | |
|---|---|---|
| Return | 388% | 32% |
Sources and methodology
- Data on this tab
- Our data supplier
- Chart on the Overview
- TradingView
Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.